Quarterly Result14 Aug 2026, 08:42 pm
Fischer Medical Ventures Declares Q1 FY27 Unaudited Results
AI Summary
Fischer Medical Ventures Ltd announced the approval of its unaudited financial results for Q1 FY27 (ended June 30, 2026), both standalone and consolidated. The Board of Directors also noted the resignation of two Independent Directors, Mr. Roberto M Pagdanganan and Mr. Sanjay Jayantilal Jain, effective August 14, 2026. Consequently, the committees of the Board were reconstituted. Additionally, the company approved the allotment of 2,05,05,909 equity shares upon conversion of warrants at an issue price of ₹23.40 per share.
Key Highlights
- Q1 FY27 unaudited financial results approved (standalone & consolidated).
- Two Independent Directors resigned effective August 14, 2026.
- Board committees reconstituted due to director resignations.
- 2,05,05,909 equity shares allotted from warrant conversion.
- Allotment price set at ₹23.40 per share.
Price Impact
More from FISCHER
More in Quarterly Result